Sree Rayalaseema Hi-Strength Hypo Downgraded to 'Sell' by MarketsMOJO Due to Negative Financial Results
Sree Rayalaseema Hi-Strength Hypo, a smallcap chemicals company, has been downgraded to 'Sell' by MarketsMojo due to negative financial results for the past 5 quarters. With a low ROCE and expensive valuation, the stock is trading at a premium and has seen a decline in profits. Domestic mutual funds hold a small stake, indicating potential red flags for investors. While the company has shown healthy long-term growth, its current performance and valuation make it a risky investment.
Sree Rayalaseema Hi-Strength Hypo, a smallcap company in the chemicals industry, has recently been downgraded to a 'Sell' by MarketsMOJO on November 13, 2024. This decision was based on the company's negative financial results for the past 5 quarters, with a significant decrease in net sales and profits. The company's return on capital employed (ROCE) is also at its lowest at 15.01%, indicating a decline in efficiency.Moreover, with a return on equity (ROE) of 10.9, the company's valuation is considered to be very expensive with a price to book value of 1.4. This is further supported by the fact that the stock is currently trading at a premium compared to its historical valuations. Despite generating a return of 11.53% in the past year, the company's profits have fallen by -43%, indicating a decline in overall performance.
Another concerning factor is that domestic mutual funds hold only 0.02% of the company, which could suggest that they are not comfortable with the current price or the business itself. This is significant as domestic mutual funds have the capability to conduct in-depth research on companies, and their small stake may be a red flag for potential investors.
In terms of other factors, the company has a low debt to equity ratio and has shown healthy long-term growth in net sales and operating profit. However, the stock is currently in a mildly bullish range, with its MACD and KST technical factors also being bullish.
In conclusion, while Sree Rayalaseema Hi-Strength Hypo may have potential for long-term growth, its current financial performance and valuation make it a risky investment. Investors are advised to carefully consider all factors before making any decisions regarding this stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
